Advertisement

Topics

Mental Health Reports

13:03 EST 15th December 2018 | BioPortfolio

Depression and Anxiety Disorders Drug Development Pipeline Review, 2018 [Report Updated: 21092018] Prices from USD $3396

Depression and Anxiety Disorders Drug Development Pipeline Review, 2018SummaryThis report provides an overview of the pipeline landscape for depression and anxiety disorders. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for posttraumatic stress disorder PTSD, obsessivecompulsive disorder OCD and depression, and feat...

Schizophrenia Pipeline Review, H2 2018 [Report Updated: 30102018] Prices from USD $2000

Schizophrenia Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia Pipeline Review, H2 2018, provides an overview of the Schizophrenia Central Nervous System pipeline landscape.Schizophrenia is a chronic, severe, and disabling brain disorder that generally appears in late adolescence or early adulthood. Symptoms include ...

Centre for Addiction and Mental Health Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryCentre for Addiction and Mental Health CAMH is a healthcare center that offers clinical care and health promotion services. The center offers addictions services, admitting service, child, youth and family service, dual diagnosis service, geriatric mental health service, law and mental health service, mood and anxiety program, schizophrenia program, women's services, hospital services, supp...

Post Partum Depression Maternal Depression / Postnatal Depression Global Clinical Trials Review, H1, 2018 [Report Updated: 31052018] Prices from USD $2500

Post Partum Depression Maternal Depression / Postnatal Depression Global Clinical Trials Review, H1, 2018SummaryGlobalData's clinical trial report, Post Partum Depression Maternal Depression / Postnatal Depression Global Clinical Trials Review, H1, 2018" provides an overview of Post Partum Depression Maternal Depression / Postnatal Depression clinical trials scenario. This report provides top line...

PostTraumatic Stress Disorder PTSD Pipeline Review, H2 2018 [Report Updated: 10072018] Prices from USD $2000

PostTraumatic Stress Disorder PTSD Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide PostTraumatic Stress Disorder PTSD Pipeline Review, H2 2018, provides an overview of the PostTraumatic Stress Disorder PTSD Central Nervous System pipeline landscape.Posttraumatic stress disorder PTSD is a mental health condition that's triggered b...

Schizophrenia Pipeline Review, H1 2018 [Report Updated: 10042018] Prices from USD $2000

Schizophrenia Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia Pipeline Review, H1 2018, provides an overview of the Schizophrenia Central Nervous System pipeline landscape.Schizophrenia is a chronic, severe, and disabling brain disorder that generally appears in late adolescence or early adulthood. Symptoms include ...

Cognitive Impairment Associated With Schizophrenia CIAS Pipeline Review, H2 2018 [Report Updated: 10072018] Prices from USD $2000

Cognitive Impairment Associated With Schizophrenia CIAS Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cognitive Impairment Associated With Schizophrenia CIAS Pipeline Review, H2 2018, provides an overview of the Cognitive Impairment Associated With Schizophrenia CIAS Central Nervous System pipeline landscape.Cognitive functioni...

Frontier Pharma: Schizophrenia Diverse FirstinClass Pipeline Shows Promise for Treatment of Negative and Cognitive Symptoms [Report Updated: 01052018] Prices from USD $6995

Frontier Pharma: Schizophrenia Diverse FirstinClass Pipeline Shows Promise for Treatment of Negative and Cognitive SymptomsSummarySchizophrenia is a chronic mental disorder that affects 1% of the population equivalent to 51 million people worldwide and is ranked among the top 10 causes of disability in developed countries. It is a debilitating condition that affects those afflicted, their famil...

Genomind Inc Medical Equipment Deals and Alliances Profile [Report Updated: 11052018] Prices from USD $250

SummaryGenomind Inc Genomind is a personalized medicine company that provides genetic testing services. The company offers Genecept Assay, a pharmacogenetic test designed to help clinicians optimize treatment decisions for their patients with mental illness. Its test is used to guide treatment for a range of psychiatric conditions including depression, anxiety, obsessive compulsive disorder, atten...

Genomind Inc Medical Equipment Deals and Alliances Profile [Report Updated: 16072018] Prices from USD $250

SummaryGenomind Inc Genomind is a personalized medicine company that provides genetic testing services. The company offers Genecept Assay, a pharmacogenetic test designed to help clinicians optimize treatment decisions for their patients with mental illness. Its test is used to guide treatment for a range of psychiatric conditions including depression, anxiety, obsessive compulsive disorder, atten...

Global Behavioral Rehabilitation Market Segmented by Type of Behavioral Rehabilitation, Healthcare Setting and Treatment Growth, Trends and Forecasts 2018 2023 [Report Updated: 01032018] Prices from USD $4250

The behavioral rehabilitation market is expected to witness a CAGR of 7% during the forecast period. North America dominates the global market due to the high incidence of behavioral disorders in the United States.Growing Prevalence of Behavioral DisordersAccording to the U.S. Department of Health and Human Services DHHS, it is estimated that one in every five 20% children and adolescents has a me...

Centre for Addiction and Mental Health Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13042018] Prices from USD $250

SummaryCentre for Addiction and Mental Health CAMH is a healthcare center that offers clinical care and health promotion services. The center offers addictions services, admitting service, child, youth and family service, dual diagnosis service, geriatric mental health service, law and mental health service, mood and anxiety program, schizophrenia program, women's services, hospital services, supp...

Centre for Addiction and Mental Health Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 11072018] Prices from USD $250

SummaryCentre for Addiction and Mental Health CAMH is a healthcare center that offers clinical care and health promotion services. The center offers addictions services, admitting service, child, youth and family service, dual diagnosis service, geriatric mental health service, law and mental health service, mood and anxiety program, schizophrenia program, women's services, hospital services, supp...

Global Behavioral Rehabilitation Market Segmented by Type of Behavioral Rehabilitation, Healthcare Setting and Treatment Growth, Trends and Forecasts 2018 2023 [Report Updated: 01032018] Prices from USD $1923

The behavioral rehabilitation market is expected to witness a CAGR of 7% during the forecast period. North America dominates the global market due to the high incidence of behavioral disorders in the United States.Growing Prevalence of Behavioral DisordersAccording to the U.S. Department of Health and Human Services DHHS, it is estimated that one in every five 20% children and adolescents has a me...

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy Mental Health market research data and corporate reports here